CSPC Pharmaceutical Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CSPC Pharmaceutical Group Ltd with three other
companies in this sector in Hong Kong:
Sino Biopharmaceutical Limited
sales of 14.55 billion Hong Kong Dollars [US$1.88 billion]
of which 97%
was Modernized Chinese Medicines and Chemica),
CK Life Sciences Int'l (Holdings) Incorporated
(4.92 billion Hong Kong Dollars [US$634.10 million]
of which 57%
was Health), and
The United Laboratories International Holdings Limited
(7.69 billion Hong Kong Dollars [US$991.83 million]
of which 43%
was Bulk Medicine).
CSPC Pharmaceutical Group Ltd reported sales of HK$11.39 billion (US$1.47 billion)
December of 2015.
increase of 4.0%
versus 2014, when the company's sales were HK$10.96 billion.
This was the third consecutive year of growth at CSPC Pharmaceutical Group Ltd.
Sales of Finished Drugs saw an increase
that was more than double the company's growth rate: sales were up
16.0% in 2015, from
HK$6.72 billion to HK$7.79 billion.
CSPC Pharmaceutical Group Ltd also saw significant increases in sales in
Caffeine and Other (up 8.5% to HK$678.89 million)
Not all segments of CSPC Pharmaceutical Group Ltd experienced an increase in sales in 2015:
sales of Antibiotics Series fell 27.5% to HK$1.72 billion.
CSPC Pharmaceutical Group Ltd also experienced decreases in sales in
Vitamin C Series (down 3.3% to HK$1.20 billion)